For example, IDH1 and IDH2 mutations are used for distinguishing primary from secondary gliomas, while the simultaneous presence of IDH1/2 and TP53 alterations are distinctive of the diffuse astrocytoma histology [52]. This evidence concerns the gene TP53 and central nervous system cancer.